Sinopharm Tech Holdings Ltd. has announced several key management changes. An executive director, group chief financial officer, and compliance officer have resigned. Additionally, the company has appointed a new company secretary and authorized representative. The board now includes executive directors Mr. Chiu Sin Nang Kenny and Ms. Kwok Shuk Yi, non-executive director Dr. Cheng Yanjie, and independent non-executive directors Mr. Lau Fai Lawrence, Mr. Hsu Dong An, and Mr. Heung Pik Lun.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.